Category Archives: Indian Patent Law

Republican lawmaker accuses Obama Administration of getting soft on India on IPR violations

Source : The Economic Times, 3 May, 2015 A top Republican lawmaker has accused the Obama Administration of being soft on alleged violations by India on intellectual property. “Once again, the (Obama) Administration has missed the mark,” Congressman Orrin Hatch, … Continue reading

Posted in Indian Patent Law, Intellectual Property, TRIPS, TRIPS plus, US pressure on India, USTR 301 report | Leave a comment

India fully aligned with international IPR, will safeguard its own interests, says Nirmala Sitharaman

Source : The Economic Times, 4 May, 2015 India is fully aligned with international intellectual property rights standards and “there is no need for anyone to question us”, Commerce and Industry Minister Nirmala Sitharaman said, rebuffing a US report released … Continue reading

Posted in Indian Patent Law, Intellectual Property, TRIPS, TRIPS plus, US pressure on India, USTR 301 report | Leave a comment

India will not respond under pressure on IPR issues

Source : The Hindu, 3 May, 2015 India will keep its ‘national interest’ in mind while framing its new intellectual property rights (IPR) policy and not work under pressure of any country, Commerce and Industry Minister Nirmala Sitharaman has said. … Continue reading

Posted in Indian Patent Law, Intellectual Property, TRIPS, TRIPS plus, Uncategorized, US pressure on India, USTR 301 report | Leave a comment

Intellectual property concerns: India still in US priority watch list

Source : Hindustan Times, 1 May, 2015 Based on positive developments in the past year, the US Trade Representative is keeping India on the priority watch list of countries with suspect intellectual property rights regimes. The USTR said in its … Continue reading

Posted in Indian Patent Law, Intellectual Property, TRIPS, TRIPS plus, US pressure on India, USTR 301 report | Leave a comment

A bitter pill for pharma units

Source: Hindu Business Line , 3 May 2015 The thriving Indian generic pharmaceutical industry has, over the past decade, earned its stripes globally as a source of reliable and cheap generic versions of exorbitantly priced medicines made by multi-national pharmaceutical companies. … Continue reading

Posted in data exclusivity, Indian Patent Law, Intellectual Property, US pressure on India, USTR 301 report | Leave a comment

DNP+ Press Release: Increasing IP barriers impact on generic medicines ‘Made in India’

Increasing IP barriers will have severe impact on generic medicines ‘Made in India’ Indian Prime Minister Must Resist Big Pharma Pressure to Trade Away Medicines New Delhi, 29 April 2015: At a conference titled  ‘IP as Frontline Tool for Make … Continue reading

Posted in access to medicines, Generic drug, Indian Patent Law, Intellectual Property, IPR policy, Make in India Campaign | Leave a comment

Letter from DNP+ to PM Modi on the adverse impact of IP on Affordable Generic Medicines ‘Made in India’

Dear Mrs. Sitharaman, Mr. Kant, Mr. Kher, Mr. Aggarwal, India’s role in ensuring global access to life-saving medicines is vital. India is often referred to as the ‘pharmacy of the developing world’ because of its critical role in providing affordable generic … Continue reading

Posted in Generic drug, Indian Patent Law, Make in India Campaign, patent, TRIPS, TRIPS plus | Leave a comment